spacer
home > ict > summer 2007 > part of the process
PUBLICATIONS
International Clinical Trials

Part of the Process

Jonathan Blamey and Chris Tierney of DHL Healthcare outline the challenges and responses of global clinical trials logistical operations

The clinical trial logistics market is changing, and most notable developments include an increasing need for cost effective services and improved accuracy of logistical activity. Pharmaceutical and biotech companies are responding to this in a number of ways – many are looking at specialist logistics providers for both regional and global services. Using such providers can yield significant benefits such as reduced establishment timeframes, better medication availability, improved quality of supply through active contingency planning, reduced time spent by the sponsor in managing the supply chain and improved cost effectiveness.

MARKET REQUIREMENTS

Clinical trials are becoming more complex as studies globalise and larger patient numbers are required to satisfy regulatory standards. Successful co-ordinatation of patient screening, enrolment, randomisation, study-drug distribution and inventory management is more challenging than ever. As competition to speed up the drug development process intensifies, innovative ways to increase supply chain efficiencies are key.

Efficiency of the clinical trial process and the logistics of clinical trial supplies (as well as the return of diagnostic specimens to central laboratories) is being targeted in the search for a cost effective and improved service to better meet the objectives of the clinical trial.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

spacer
Jonathan Blamey has 15 years of experience within the healthcare industry, covering medical devices, pharmaceutical services and home healthcare/pharmacy. He has also worked within regulatory affairs, project/trial management and aseptic manufacture. Jonathan holds a PhD and an MBA; and in his current role as Vice President, Product Development and Marketing with DHL Healthcare, he has responsibility for the strategic development of new and existing logistics service offerings.

Chris Tierney graduated in 1995 with a BSc in Medical Biochemistry and shortly after joined Exel’s international management training scheme. He has worked in operations, strategic marketing and product development. In 2003, Chris completed his MBA. Chris’s current role is Business Development Manager for DHL Healthcare, and he has responsibility for global sales and the strategic development of the clinical trials logistics offerings.

spacer
Jonathan Blamey
spacer
spacer
spacer
Chris Tierney
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Premier Research Deepens Support for Oncology Sponsors By Expanding Oncology Leadership Team

As the number of next-generation oncology therapies in the clinical trial pipeline surges, Premier Research today announced three new oncology leadership team hires to strengthen the company’s expertise in the fast-growing areas of cell and gene therapies and immuno-oncology.
More info >>

White Papers
 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement